![CCO Medical Specialties Podcast artwork](https://is1-ssl.mzstatic.com/image/thumb/Podcasts113/v4/90/c1/d0/90c1d04d-d72e-f0a7-60fc-1f352572bec0/mza_14565753254283220928.jpg/100x100bb.jpg)
Emerging NASH Treatments
CCO Medical Specialties Podcast
English - July 01, 2020 18:49 - 40 minutes - 36.4 MBCourses Education Technology cardiology hep clinical care options hiv immunology family practice internal medicine pharmacist continued education oncology Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Role of the Diabetes Care and Education Specialist in CGM
Next Episode: New Developments in Gene Therapy for Muscular Dystrophy
Hear Philip N. Newsome, PhD, FRCPE, discuss the agents in late-phase clinical trials and their potential use in the treatment of NASH and fibrosis, including those in phase III such as:
Obeticholic acidCenicrivirocResmetiromAramcholDownload the slides from this podcast at:
https://bit.ly/3eJYKvW
See more NASH topics at:
https://bit.ly/3ezkBq6